Report Detail

Pharma & Healthcare Global Prostate Cancer Treatment Drugs Market Research Report 2019

  • RnM3127274
  • |
  • 14 March, 2019
  • |
  • Global
  • |
  • 94 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Prostate cancer is the most common cancer among men, the key risk factors for prostate cancer development is being old age, genetic, obesity and race.

The global Prostate Cancer Treatment Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Prostate Cancer Treatment Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Prostate Cancer Treatment Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Tolmar
Astellas Pharma
AstraZeneca
Ferring Pharmaceuticals
Johnson & Johnson
Abbott
Sanofi
Ipsen
Novartis
Bayer

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Enzalutamid
Abiraterone
Leuprolide
Goserelin
Triptorelin
Histrelin
Degarelix
Sipuleucel-T
Docetaxel
Cabazitaxel

Segment by Application
Hospital
Research Institution
Clinic
Drugstore


Table of Contents

    Executive Summary

      1 Prostate Cancer Treatment Drugs Market Overview

      • 1.1 Product Overview and Scope of Prostate Cancer Treatment Drugs
      • 1.2 Prostate Cancer Treatment Drugs Segment by Type
        • 1.2.1 Global Prostate Cancer Treatment Drugs Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Enzalutamid
        • 1.2.3 Abiraterone
        • 1.2.4 Leuprolide
        • 1.2.5 Goserelin
        • 1.2.6 Triptorelin
        • 1.2.7 Histrelin
        • 1.2.8 Degarelix
        • 1.2.9 Sipuleucel-T
        • 1.2.10 Docetaxel
        • 1.2.11 Cabazitaxel
      • 1.3 Prostate Cancer Treatment Drugs Segment by Application
        • 1.3.1 Prostate Cancer Treatment Drugs Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospital
        • 1.3.3 Research Institution
        • 1.3.4 Clinic
        • 1.3.5 Drugstore
      • 1.4 Global Prostate Cancer Treatment Drugs Market by Region
        • 1.4.1 Global Prostate Cancer Treatment Drugs Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Prostate Cancer Treatment Drugs Market Size
        • 1.5.1 Global Prostate Cancer Treatment Drugs Revenue (2014-2025)
        • 1.5.2 Global Prostate Cancer Treatment Drugs Production (2014-2025)

      2 Global Prostate Cancer Treatment Drugs Market Competition by Manufacturers

      • 2.1 Global Prostate Cancer Treatment Drugs Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Prostate Cancer Treatment Drugs Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Prostate Cancer Treatment Drugs Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Prostate Cancer Treatment Drugs Production Sites, Area Served, Product Types
      • 2.5 Prostate Cancer Treatment Drugs Market Competitive Situation and Trends
        • 2.5.1 Prostate Cancer Treatment Drugs Market Concentration Rate
        • 2.5.2 Prostate Cancer Treatment Drugs Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Prostate Cancer Treatment Drugs Production Market Share by Regions

      • 3.1 Global Prostate Cancer Treatment Drugs Production Market Share by Regions
      • 3.2 Global Prostate Cancer Treatment Drugs Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Prostate Cancer Treatment Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Prostate Cancer Treatment Drugs Production
        • 3.4.1 North America Prostate Cancer Treatment Drugs Production Growth Rate (2014-2019)
        • 3.4.2 North America Prostate Cancer Treatment Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Prostate Cancer Treatment Drugs Production
        • 3.5.1 Europe Prostate Cancer Treatment Drugs Production Growth Rate (2014-2019)
        • 3.5.2 Europe Prostate Cancer Treatment Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Prostate Cancer Treatment Drugs Production (2014-2019)
        • 3.6.1 China Prostate Cancer Treatment Drugs Production Growth Rate (2014-2019)
        • 3.6.2 China Prostate Cancer Treatment Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Prostate Cancer Treatment Drugs Production (2014-2019)
        • 3.7.1 Japan Prostate Cancer Treatment Drugs Production Growth Rate (2014-2019)
        • 3.7.2 Japan Prostate Cancer Treatment Drugs Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Prostate Cancer Treatment Drugs Consumption by Regions

      • 4.1 Global Prostate Cancer Treatment Drugs Consumption by Regions
      • 4.2 North America Prostate Cancer Treatment Drugs Consumption (2014-2019)
      • 4.3 Europe Prostate Cancer Treatment Drugs Consumption (2014-2019)
      • 4.4 China Prostate Cancer Treatment Drugs Consumption (2014-2019)
      • 4.5 Japan Prostate Cancer Treatment Drugs Consumption (2014-2019)

      5 Global Prostate Cancer Treatment Drugs Production, Revenue, Price Trend by Type

      • 5.1 Global Prostate Cancer Treatment Drugs Production Market Share by Type (2014-2019)
      • 5.2 Global Prostate Cancer Treatment Drugs Revenue Market Share by Type (2014-2019)
      • 5.3 Global Prostate Cancer Treatment Drugs Price by Type (2014-2019)
      • 5.4 Global Prostate Cancer Treatment Drugs Production Growth by Type (2014-2019)

      6 Global Prostate Cancer Treatment Drugs Market Analysis by Applications

      • 6.1 Global Prostate Cancer Treatment Drugs Consumption Market Share by Application (2014-2019)
      • 6.2 Global Prostate Cancer Treatment Drugs Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Prostate Cancer Treatment Drugs Business

      • 7.1 Tolmar
        • 7.1.1 Tolmar Prostate Cancer Treatment Drugs Production Sites and Area Served
        • 7.1.2 Prostate Cancer Treatment Drugs Product Introduction, Application and Specification
        • 7.1.3 Tolmar Prostate Cancer Treatment Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Astellas Pharma
        • 7.2.1 Astellas Pharma Prostate Cancer Treatment Drugs Production Sites and Area Served
        • 7.2.2 Prostate Cancer Treatment Drugs Product Introduction, Application and Specification
        • 7.2.3 Astellas Pharma Prostate Cancer Treatment Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 AstraZeneca
        • 7.3.1 AstraZeneca Prostate Cancer Treatment Drugs Production Sites and Area Served
        • 7.3.2 Prostate Cancer Treatment Drugs Product Introduction, Application and Specification
        • 7.3.3 AstraZeneca Prostate Cancer Treatment Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Ferring Pharmaceuticals
        • 7.4.1 Ferring Pharmaceuticals Prostate Cancer Treatment Drugs Production Sites and Area Served
        • 7.4.2 Prostate Cancer Treatment Drugs Product Introduction, Application and Specification
        • 7.4.3 Ferring Pharmaceuticals Prostate Cancer Treatment Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Johnson & Johnson
        • 7.5.1 Johnson & Johnson Prostate Cancer Treatment Drugs Production Sites and Area Served
        • 7.5.2 Prostate Cancer Treatment Drugs Product Introduction, Application and Specification
        • 7.5.3 Johnson & Johnson Prostate Cancer Treatment Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Abbott
        • 7.6.1 Abbott Prostate Cancer Treatment Drugs Production Sites and Area Served
        • 7.6.2 Prostate Cancer Treatment Drugs Product Introduction, Application and Specification
        • 7.6.3 Abbott Prostate Cancer Treatment Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Sanofi
        • 7.7.1 Sanofi Prostate Cancer Treatment Drugs Production Sites and Area Served
        • 7.7.2 Prostate Cancer Treatment Drugs Product Introduction, Application and Specification
        • 7.7.3 Sanofi Prostate Cancer Treatment Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Ipsen
        • 7.8.1 Ipsen Prostate Cancer Treatment Drugs Production Sites and Area Served
        • 7.8.2 Prostate Cancer Treatment Drugs Product Introduction, Application and Specification
        • 7.8.3 Ipsen Prostate Cancer Treatment Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Novartis
        • 7.9.1 Novartis Prostate Cancer Treatment Drugs Production Sites and Area Served
        • 7.9.2 Prostate Cancer Treatment Drugs Product Introduction, Application and Specification
        • 7.9.3 Novartis Prostate Cancer Treatment Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Bayer
        • 7.10.1 Bayer Prostate Cancer Treatment Drugs Production Sites and Area Served
        • 7.10.2 Prostate Cancer Treatment Drugs Product Introduction, Application and Specification
        • 7.10.3 Bayer Prostate Cancer Treatment Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served

      8 Prostate Cancer Treatment Drugs Manufacturing Cost Analysis

      • 8.1 Prostate Cancer Treatment Drugs Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Prostate Cancer Treatment Drugs
      • 8.4 Prostate Cancer Treatment Drugs Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Prostate Cancer Treatment Drugs Distributors List
      • 9.3 Prostate Cancer Treatment Drugs Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Prostate Cancer Treatment Drugs Market Forecast

      • 11.1 Global Prostate Cancer Treatment Drugs Production, Revenue Forecast
        • 11.1.1 Global Prostate Cancer Treatment Drugs Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Prostate Cancer Treatment Drugs Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Prostate Cancer Treatment Drugs Price and Trend Forecast (2019-2025)
      • 11.2 Global Prostate Cancer Treatment Drugs Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Prostate Cancer Treatment Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Prostate Cancer Treatment Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Prostate Cancer Treatment Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Prostate Cancer Treatment Drugs Production, Revenue Forecast (2019-2025)
      • 11.3 Global Prostate Cancer Treatment Drugs Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Prostate Cancer Treatment Drugs Consumption Forecast (2019-2025)
        • 11.3.2 Europe Prostate Cancer Treatment Drugs Consumption Forecast (2019-2025)
        • 11.3.3 China Prostate Cancer Treatment Drugs Consumption Forecast (2019-2025)
        • 11.3.4 Japan Prostate Cancer Treatment Drugs Consumption Forecast (2019-2025)
      • 11.4 Global Prostate Cancer Treatment Drugs Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Prostate Cancer Treatment Drugs Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Summary:
        Get latest Market Research Reports on Prostate Cancer Treatment Drugs . Industry analysis & Market Report on Prostate Cancer Treatment Drugs is a syndicated market report, published as Global Prostate Cancer Treatment Drugs Market Research Report 2019. It is complete Research Study and Industry Analysis of Prostate Cancer Treatment Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $2,900.00
        $4,350.00
        $5,800.00
        2,311.30
        3,466.95
        4,622.60
        2,697.00
        4,045.50
        5,394.00
        443,352.00
        665,028.00
        886,704.00
        241,947.00
        362,920.50
        483,894.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report